M
Moishe Liberman
Researcher at Université de Montréal
Publications - 164
Citations - 5770
Moishe Liberman is an academic researcher from Université de Montréal. The author has contributed to research in topics: Medicine & Lung cancer. The author has an hindex of 31, co-authored 143 publications receiving 4698 citations. Previous affiliations of Moishe Liberman include McGill University & University of Turin.
Papers
More filters
Journal ArticleDOI
Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients.
Nicolas V. Christou,John S. Sampalis,Moishe Liberman,Didier Look,Stephane Auger,A. P. H. Mclean,Lloyd D. MacLean +6 more
TL;DR: This study shows that weight-loss surgery significantly decreases overall mortality as well as the development of new health-related conditions in morbidly obese patients.
Journal ArticleDOI
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Patrick M. Forde,Jonathan Spicer,Shun Lu,Mariano Provencio,Tetsuya Mitsudomi,Mark M. Awad,Enriqueta Felip,Stephen R. Broderick,Julie R. Brahmer,J. Swanson,Keith M. Kerr,Changli Wang,Tudor Ciuleanu,Gene Brian Saylors,Fumihiro Tanaka,Hiroyuki Ito,Keke Chen,Moishe Liberman,Everett E. Vokes,Janis M. Taube,C. Dorange,Jun Bo Cai,Joseph Fiore,Anthony Jarkowski,David Balli,Mark Sausen,Dimple Pandya,Christophe Y Calvet,Nicolas Girard +28 more
TL;DR: In patients with resectable NSCLC, neoadjuvant nivolumab plus chemotherapy resulted in significantly longer event-free survival and a higher percentage of patients with a pathological complete response than chemotherapy alone.
Journal ArticleDOI
Advanced or basic life support for trauma: meta-analysis and critical review of the literature.
TL;DR: The aggregated data in the literature have failed to demonstrate a benefit for on-site ALS provided to trauma patients and support the scoop and run approach.
Journal ArticleDOI
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).
Nasser K. Altorki,Xiaofei Wang,Dennis A. Wigle,Lin Gu,Gail Darling,Ahmad S Ashrafi,Rodney Landrenau,Daniel L. Miller,Moishe Liberman,David R. Jones,Robert J. Keenan,Massimo Conti,Gavin M. Wright,Linda J. Veit,Suresh S. Ramalingam,Mohamed Kamel,Harvey I. Pass,John D. Mitchell,Thomas E. Stinchcombe,Everett E. Vokes,Leslie J. Kohman +20 more
TL;DR: The post-hoc analysis showed that perioperative mortality and morbidity did not seem to differ between lobar and sublobar resection in physically and functionally fit patients with clinical T1aN0 non-small-cell lung cancer.
Journal ArticleDOI
The Impact of Weight Reduction Surgery on Health-Care Costs in Morbidly Obese Patients
TL;DR: Weight-reduction surgery in morbidly obese patients produces effective weight loss and decreases long-term direct health-care costs, and the initial costs of surgery can be amortized over 3.5 years.